Inhibitory effects of a collagen–mineral complex on deterioration of bone mass and bone quality in ovariectomized mice

[1] Kanis JA(2002)International variations in hip fracture probabilities: implications for risk assessment J Bone Miner Res 17 1237-1244

[2] Johnell O(2013)Recognition of bisphosphonate-related osteonecrosis of the jaw among oral and maxillofacial radiologists: results from a questionnaire-based survey in Japan Oral Radiol 4 37-42

[3] DeLaet C(2007)Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ) Clin Cases Miner Bone Metab 282 637-645

[4] Jonsson B(1999)Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene JAMA 13 326-334

[5] Oden A(2001)Glucocorticoid-induced osteoporosis Curr Opin Rheumatol 13 158-170

[6] Ogelsby AK(2002)A randomized trial of sodium fluoride (60 mg) +/− estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures Osteoporos Int 285 785-795

[7] Taguchi A(2001)Osteoporosis prevention, diagnosis, and therapy JAMA 323 878-883

[8] Akiyama H(1990)A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women N Engl J Med 120 97-103

[9] Koseki T(1994)Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss Ann Intern Med 98 331-335

[10] Kimishige S(1995)Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial Am J Med 20 37-43

[1] Kanis JA(2002)International variations in hip fracture probabilities: implications for risk assessment J Bone Miner Res 17 1237-1244

[2] Johnell O(2013)Recognition of bisphosphonate-related osteonecrosis of the jaw among oral and maxillofacial radiologists: results from a questionnaire-based survey in Japan Oral Radiol 4 37-42

[3] DeLaet C(2007)Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ) Clin Cases Miner Bone Metab 282 637-645

[4] Jonsson B(1999)Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene JAMA 13 326-334

[5] Oden A(2001)Glucocorticoid-induced osteoporosis Curr Opin Rheumatol 13 158-170

[6] Ogelsby AK(2002)A randomized trial of sodium fluoride (60 mg) +/− estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures Osteoporos Int 285 785-795

[7] Taguchi A(2001)Osteoporosis prevention, diagnosis, and therapy JAMA 323 878-883

[8] Akiyama H(1990)A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women N Engl J Med 120 97-103

[9] Koseki T(1994)Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss Ann Intern Med 98 331-335

[10] Kimishige S(1995)Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial Am J Med 20 37-43